Advanced Biomedical Technologies Inc. (ABMT) SEC Filing 10-K Annual report for the fiscal year ending Saturday, December 31, 2011

Advanced Biomedical Technologies Inc.

CIK: 1780097 Ticker: ABMT

View differences made from one year to another to evaluate Advanced Biomedical Technologies Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Advanced Biomedical Technologies Inc..


Assess how Advanced Biomedical Technologies Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Advanced Biomedical Technologies Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2012 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
Ticker: ABMT
CIK: 1385799
Form Type: 10-K Annual Report
Accession Number: 0001387131-12-000355
Submitted to the SEC: Tue Feb 14 2012 5:45:07 PM EST
Accepted by the SEC: Wed Feb 15 2012
Period: Saturday, December 31, 2011
Industry: Orthopedic Prosthetic And Surgical Appliances And Supplies

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: